February 27 - 28, 2017
Keynote Speaker: Padmanee Sharma (The University of Texas MD Anderson Cancer Center)
Discover the latest on immunotherapeutic strategies that are currently being employed to treat some of the most devastating forms of cancer from leading experts in immunotherapy.
This event is sold out.
Wednesday, March 1, 2017 | 9:00 AM - 5:00 PM
Keynote Speaker: Harlan Robins (Fred Hutchinson Cancer Research Center)
This symposium will explore the emerging field of quantitative immuno-oncology, covering the breadth of scientific topics and methods needed to quantify interactions between tumors and the immune system.
Monday, March 13, 2017 | 9:00 AM - 5:00 PM
Speakers: Michael G. Agadjanyan (The Institute for Molecular Medicine), Bernardino Ghetti (Indiana University School of Medicine), Khalid Iqbal (New York State Institute for Basic Research in Developmental Disabilities), Viktoriya Morozova (College of Staten Island, The City University of New York), Andreas Muhs AC Immune SA), Einar M. Sigurdsson (New York University School of Medicine), Qian Wu (New York University School of Medicine), and Henrik Zetterberg (University of Gothenburg, Sweden)
This event will cover the translational potential of immunotherapy for tauopathies, reviewing the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic approach.
March 15 - 16, 2017
Experience a public-facing dialogue exploring the nuanced ethical and scientific rationale behind randomized controlled clinical trials, accelerated alternatives, and the implications of these discussions on drug approval and patient interests.
Tuesday, March 21, 2017 | 12:00 PM - 5:00 PM
Speakers: Tsuneya Ikezu (Boston University School of Medicine), David Issadore (University of Pennsylvania), Xandra Breakefield (Massachusetts General Hospital), Efrat Levy (NYU School of Medicine), Robert A. Rissman (University of California San Diego, School of Medicine), and Andrew West (The University of Alabama at Birmingham)
In this symposium we will explore the contribution of extracellular vesicles to pathological processes underlying neurodegenerative disorders, and the appeal of exosomes as biomarkers and targets for the development of novel therapeutics.
Monday, February 6, 2017 | 1:30 PM - 4:30 PM
Speakers: Scott Keeney (Memorial Sloan Kettering Cancer Center), Molly Przeworski (Columbia University), Agata Smogorzewska (The Rockefeller University), and Shan Zha (Columbia University Medical Center), Upasana Roy (Stony Brook University, Schärer Lab), and Simona Giunta (The Rockefeller University, Funabiki Lab)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Saturday, January 28, 2017 | 11:00 AM - 4:00 PM
This event gives professionals from across the biopharmaceutical space — from scientists and industry executives, through healthcare providers and insurers to investors — a visceral understanding of how biopharma innovation dynamics are evolving, mimicking decision-making under pressure in a complex and changing environment.
Thursday, January 19, 2017 | 9:00 AM - 5:30 PM
Organizers: Iban Ubarretxena (Mount Sinai School of Medicine), John Hunt (Columbia University), David Jeruzalmi (City College of New York), Sonya Dougal and Caitlin McOmish (The New York Academy of Sciences)
The New York Area Structural Biology Discussion Group convenes twice annually and presents talks and poster sessions from graduate students, postdocs, and laboratory heads.
This event is sold out.
Tuesday, December 6, 2016 | 9:00 AM - 5:00 PM
Speakers: Katerina Akassoglou (University of California, San Francisco), Robert Dempsey (University of Wisconsin), Paula Grammas (University of Rhode Island), Steven Greenberg (Massachusetts General Hospital and Harvard Medical School), Jaime Grutzendler (Yale University), Costantino Iadecola (Weill Cornell Medicine), Jeffrey Iliff (Oregon Health & Science University), Berislav Zlokovic (Keck School of Medicine of USC), Heather Snyder (Alzheimer's Association), Zorina Galis (NIH)
This symposium will highlight basic research and clinical science elucidating the mechanisms underlying the contribution of inflammatory pathways to vascular cognitive impairment and dementia (VCID).
Edited by Charles W. Fox
(University of Kentucky) and Timothy A. Mousseau
(University of South Carolina)
Eleven scholarly review articles discuss topics in evolutionary biology and genetics
Speakers: Tyrone D. Cannon (Yale University), K. Ranga Rama Krishnan (Rush Medical College), Husseini Manji (Janssen Research & Development, LLC), Vaibhav Narayan (Janssen Research & Development, LLC), Daniel Pine (National Institute of Mental Health, US National Institutes of Mental Health), and B. Timothy Walsh (New York State Psychiatric Institute, Columbia University)
At this symposium, scientists, physicians, clinicians, other allied healthcare providers, policy makers, and patients explored new scientific understanding of the neurobiology of a range of mental illnesses.
Edited by Gerald D. Wright
Nine scholarly review articles discussing aspects of antibiotic resistance
Speakers: Jan van Deursen (The Mayo Clinic), Vadim Gladyshev (Harvard University), Matt Kaeberlein (University of Washington), Vera Gorbunova (University of Rochester), Nicholas Stroustrup (Harvard University), and Arlan Richardson (University of Oklahoma)
This eBriefing documents how prominent researchers in the field came together to explore the interplay between aging, nutrition, and metabolism, as well as the important role that novel technologies will play in current and future studies.